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MaIn recent years, several technical developments in the ﬁeld of cardiac computed tomography (CT) have made possible the
extraction of functional information from an anatomy-based examination. Several different lines have been explored and
will be reviewed in the present paper, namely: 1) myocardial perfusion imaging; 2) transluminal attenuation gradients and
corrected coronary opaciﬁcation indexes; 3) fractional ﬂow reserve computed from CT; and 4) extrapolation from
atherosclerotic plaque characteristics. In view of these developments, cardiac CT has the potential to become in the near
future a truly 2-in-1 noninvasive evaluation for coronary artery disease. (J Am Coll Cardiol Img 2015;8:1322–35)
© 2015 by the American College of Cardiology Foundation.L ess than 10 years have passed since the publica-tion of the ﬁrst studies reporting on the diag-nostic performance of the 64-slice scanners,
which led to thewide adoption of cardiac computed to-
mography (CT) in clinical practice (1,2), and we are still
witnessing impressive technical improvements in this
ﬁeld. These advances have led to signiﬁcant improve-
ments in temporal resolution and volume coverage
and associated reductions in scan time, contrast, and
radiation dose, which have made possible the progres-
sive development of protocols aimed at extracting
functional information about coronary artery disease
(CAD) lesions. This is of utmost importance because
clinical decision making, namely the decision to pro-
ceed to a revascularization procedure, is based on the
expected functional effect of CAD lesions, as it has
been well documented that there is no prognostic
beneﬁt of revascularization in the absence of func-
tional signiﬁcance (3–5). Several noninvasive diag-
nostic tools are already readily available, from the
simple exercise electrocardiogram (ECG) to stress
echocardiography, single-photon emission computed
tomography (SPECT), and stress cardiac magnetic
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related not only to their diagnostic performance, but
also to availability and patient-related features (6).
The potential advantage of cardiac CT in this ﬁeld
comes from both its wide clinical adoption in recent
years and the attractive concept of having a 2-in-1
examination, providing anatomic plus functional
CAD evaluation. In this concept, cardiac CT might
be able to not only rule out CAD with a very high
accuracy, but also provide additional functional
information in case CAD is documented, moving
beyond the usual classiﬁcation of obstructive versus
nonobstructive to a more functional-based interpre-
tation of signiﬁcant versus nonsigniﬁcant CAD, a
feature that is linked more closely to the current
clinical decision algorithm.
MYOCARDIAL PERFUSION IMAGING
The diagnostic accuracy and prognostic value of car-
diac CT in patients with low to intermediate CAD
likelihood has been largely established. Nevertheless,
the performance of this technique in patients with in-
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AB BR E V I A T I O N S
AND ACRONYM S
CAD = coronary artery disease
CCO = corrected coronary
opaciﬁcation
CMR = cardiac magnetic
resonance
CT = computed tomography
CTA = computed tomography
angiography
FFR = fractional ﬂow reserve
HU = Hounsﬁeld units
ICA = invasive coronary
angiography
MBF = myocardial blood ﬂow
MPI = myocardial perfusion
imaging
SPECT = single-photon
emission computed
tomography
TAG = transluminal
attenuation gradients
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1323with a low speciﬁcity. Themajor advantage of coronary
computed tomographic angiography (CTA) lies in a
very high negative predictive value, which rules out
CAD with high reliability. However, the positive pre-
dictive value of the test is not sufﬁciently high,
ascribed to a relatively high false positive rate in
selected populations (7). This is mainly due to the
presence of artifacts (i.e., blooming, beam hardening)
related to coronary calciﬁcation in the setting of
the still limited spatial resolution of this technique
(8). The presence of heavy, particularly concentric,
calciﬁcation hampers the clear visualization of lumen
and its distinction from atherosclerotic plaque,
occasionally resulting in false positive ﬁndings
and/or inconclusive studies, and thus leading to po-
tential unnecessary referral to invasive coronary
angiography (ICA) or to further diagnostic tests.
Overall, these limitations broaden the spectrum of
restrictions of the technique in addition to other
exclusion criteria, such as patients with arrhythmia
and inability to achieve target heart rate (due to
motion artifacts) and patients at risk of contrast-
induced nephropathy.
However, the fact that obstructive lesions identi-
ﬁed by cardiac CT have demonstrated a weak corre-
lation with the presence of ischemia underscores the
need for a hemodynamic assessment in addition to
the anatomic evaluation (9,10).
Despite recent conﬂicting ﬁndings from a sub-
analysis of the COURAGE (Clinical Outcomes Utilizing
Revascularization and Aggressive Drug Evaluation)
and STICH (Surgical Treatment for Ischemic Heart
Failure) trials, which have casted some doubts
regarding the prognostic value of inducible ischemia as
the sole indicator of revascularization, clinical deci-
sion making remains linked to the presence or absence
of myocardial ischemia, given the largely established
prognostic value of stress myocardial perfusion imag-
ing (11,12). Furthermore, the estimation of the phy-
siological effect of a given epicardial obstruction
(particularly of intermediate lesions) is highly relevant
to determining a treatment strategy, independently of
the pre-test CAD likelihood.
Overall, the previously mentioned shortcomings
have set the foundation for major technical deve-
lopments achieved during the past decade, aimed at
evaluating the functional signiﬁcance of coronary
stenosis by means of cardiac CT. One of the emerging
strategies in this regard is CT myocardial perfusion
imaging (MPI) under pharmacological stress, a tech-
nique that is positioned as the only tool capable of
detecting a stenosis, which establishes its hemody-
namic signiﬁcance. Two different approaches are
available for CT-MPI: static or dynamic (Table 1).Static CT-MPI acquisitions comprise the
evaluation of myocardial perfusion obtained
from a single dataset acquired during ﬁrst-
pass enhancement and enable a qualitative
assessment of differences in contrast en-
hancement based on myocardial perfusion
(13–15). In this approach, attenuation levels of
the ischemic areas are compared with the
signal density of the remote (normal) myo-
cardium areas. Accordingly, patients with
balanced myocardial ischemia may not be
easily identiﬁed using this technique, al-
though it is noteworthy that diffuse ischemia
might be identiﬁed as a myocardium with ho-
mogeneously low myocardial attenuation
levels. In parallel, peak myocardial attenua-
tion may be missed if bolus timing is not ac-
curate, thus potentially affecting the ability to
discriminate between normal and ischemic
regions (16).
However, dynamic CT-MPI provides a
quantitative estimation of myocardial time-
attenuation curves and other parameters such as
myocardial blood ﬂow (MBF) (17–21). The concept of
dynamic CT-MPI is based on the evaluation of mul-
tiple sequential CT datasets of myocardial attenua-
tion levels after the injection of a contrast bolus,
enabling the generation of time-attenuation curves
during arrival and washout of contrast to and from
the myocardium and aorta over time. Quantiﬁcation
of absolute MBF using this technique has been vali-
dated in animal models using variable degrees of
coronary stenosis, showing a good correlation be-
tween CT-MBF and coronary blood ﬂow as well as
between CT-MBF and fractional ﬂow reserve (FFR)
(22,23). Several clinical studies have been conducted
aiming to assess absolute quantiﬁcation of MBF using
stress dynamic CT-MPI in humans (21,24,25). Indeed,
cutoff points between 75 and 78 ml/100 ml/min have
been proposed as the optimal threshold values for the
discrimination between signiﬁcant and nonsigniﬁcant
lesions (21,26).
The core limitation of dynamic CT-MPI is a signif-
icantly increased radiation dose compared with static
CT-MPI, as well as the need for longer breath-holding
that warrants the use of further motion correction
algorithms (27,28). Indeed, effective radiation dose of
dynamic CT-MPI using 128-detector dual-source
scanners has been reported to range between 9.2
and 12.5 mSv (28). Moreover, a number of studies
have suggested that MBF measurements might be
slightly underestimated by dynamic CT-MPI (24,29).
Static CT-MPI demands an additional scan to con-
ventional coronary CTA protocol; thereby, radiation
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1324exposure of this approach is directly related to the
acquisition mode. Although acquisitions using
128-slice dual-source high-pitch CT-MPI have been
reported to achieve a radiation exposure of only 2.5
mSv for the entire stress/rest CT protocol, this has not
been replicated in other studies (30).
It is noteworthy that both approaches (static and
dynamic CT-MPI) have shown a high diagnostic per-
formance for the detection of perfusion defects, and a
recent study has shown a good agreement between
both methods (31).
The aim of stress CT-MPI is to complement coro-
nary CTA ﬁndings during a single procedure.
Numerous single-center studies have validated this
application using different scanners, pharmacological
agents (adenosine, dipyridamole, and regadenoson),
and acquisition protocols (14,15,17–19,30–33). Overall,
these studies showed good agreement between stress
CT-MPI and SPECT, ICA, and/or stress CMR, with the
obvious advantage of providing additional informa-
tion regarding the presence and extent of underlying
coronary obstruction. Indeed, most of the aforemen-
tioned studies indicated that the addition of stress
CT-MPI provides a signiﬁcant incremental value over
anatomic evaluation alone by coronary CTA for the
detection of reversible perfusion defects. Stress CMR
is currently considered the noninvasive reference
standard in terms of MPI, and CT-MPI has demon-
strated a 86% sensitivity, 98% speciﬁcity, 94% posi-
tive predictive value, and 96% negative predictive
value for the detection of perfusion defects compared
with CMR (33). Stress CT-MPI has also been recently
compared to FFR, showing that in territories where
coronary CTA and CT-MPI are concordant, the com-
bined evaluation is highly accurate in the detection
and exclusion of ischemia (32). In that study, the
speciﬁcity and positive predictive value increased
from 84% to 98% and from 82% to 97%, respectively,
after adding CT-MPI to CTA.
A recently published multicenter study (CORE320
[Coronary Artery Evaluation using 320-row Multi-
detector Computed Tomography Angiography and
Myocardial Perfusion]) has conﬁrmed earlier ﬁndings
on a larger scale. In this study, the overall perfor-
mance of CT-MPI in the diagnosis of obstructive CAD
was higher than that of SPECT. Whereas SPECT
demonstrated a higher speciﬁcity, CT-MPI showed a
higher sensitivity, partly due to the higher sensitivity
for left main and multivessel disease assessment (34).
It should be noted that the reference used in
this study was a conservative anatomic threshold of
50% stenosis by ICA. More recently, a randomized,
multicenter, multivendor study demonstrated non-
inferiority of regadenoson CT-MPI compared withSPECT for the detection of myocardial ischemia, with
an agreement rate of 0.87 (95% conﬁdence interval
[CI]: 0.77 to 0.97). In this study, the diagnostic
accuracy of CT-MPI and coronary CTA alone were 0.85
(95% CI: 0.78 to 0.91) and 0.69 (95% CI: 0.60 to 0.77),
respectively (35).
As previously mentioned, static CT-MPI requires 2
scans: 1 with pharmacological stress and the other
during rest (Figure 1). In general, retrospective ECG
gating is used for stress acquisitions with tube current
modulation aimed at decreasing radiation dose as low
as possible. Retrospective acquisitions are less sus-
ceptible to artifacts related to increased and/or
irregular heart rate and allow the possibility of having
systolic and diastolic phases that aid the discrimina-
tion between motion artifacts and perfusion defects.
Rest scans are usually performed in prospective
mode to achieve the lowest radiation dose. Overall,
this combined scan allows the simultaneous evalua-
tion of coronary anatomy as well as the functional
signiﬁcance of CAD by assessing myocardial perfusion
after hyperemia. Myocardial perfusion defects, iden-
tiﬁed by hypoenhanced areas, can be reversible
(ischemia) or ﬁxed (scar). If needed, a third non-
contrast scan can be added to conﬁrm the presence of
scar (delayed-enhancement) attributed mainly to an
expansion in the extracellular volume, which has
been shown to predict clinical outcome in patients
with acute myocardial infarction (36,37). This
scan can be performed in a prospective mode using a
very low radiation dose. Nevertheless, chronic infarct
sizes evaluated by delayed-enhancement CT are
signiﬁcantly smaller than those from matching CMR
(38). It is also worth mentioning that CT and magnetic
resonance, as opposed to SPECT, provide an evalu-
ating of transmural extension, with a potential
advantage for CT due to a lower contrast-to-noise
ratio (39).
In the past few years, there has been a growing in-
terest in the development of a noninvasive “1-stop
shop” tool that can evaluate in a single session both
coronary anatomy and the presence of ischemia. The
spectrum of patients who might be eligible for cardiac
CT might be widened by eventually including
patients who were formerly excluded from most pro-
tocols, such as patients outside of the borders of
intermediate CAD probability. Indeed, it is ex-
pected that in the future, the order or extent of the scan
might be selected according to the pre-test CAD like-
lihood (anatomy [rest] only, anatomy with eventual
perfusion [rest plus stress], stress-perfusion, and
stress-perfusion plus delayed-enhancement). Actu-
ally, technical developments such as faster gantry
rotation speed and intracycle motion correction
FIGURE 1 Myocardial Perfusion Imaging by CT
A 61-year-old man who was a previous smoker, had hypercholesterolemia, and had a body
mass index of 32 kg/m2. The patient had a history of established 3-vessel disease on previous
invasive coronary angiography and currently had stable angina. Stress (dipyridamole)
perfusion computed tomography (CT) (A) (mid-diastole 4- and 2-chamber multiplanar
reconstruction (MPR) using a smooth ﬁlter are shown) was performed in view of the high
pre-test coronary artery disease likelihood using conventional static CT-MPI protocol with a
256-detector scanner and demonstrated an extensive reversible perfusion defect at the
anterior-wall (*) and a mild subendocardial reversible perfusion defect at the inferior wall
(arrow). Single photon emission CT conﬁrmed the ﬁndings (B). The patient was referred to
invasive coronary angiography (C), which showed 3-vessel disease with totally occluded
right coronary artery, critical lesion at the left anterior descending artery, and severe lesion
at the distal circumﬂex artery. MPI ¼ myocardial perfusion imaging.
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1325algorithms aid the attenuation of artifacts related to
high or irregular heart rates and, therefore, might lead
in the future to an accurate assessment of the coronary
tree with stress-only acquisitions, thus further saving
radiation dose (40). The issue of radiation is of utmost
importance when faced with other functional modal-
ities that do not require ionizing radiation, like stress
CMR and stress echocardiography, but in recent years,
several hardware (e.g., dual-source, high-volume
coverage, more powerful Roentgen tubes, dedicated
ﬁlters) and software (e.g., low Kv scanning, prospec-
tive ECG-gated scan protocols, iterative reconstruction
techniques) developments have led to an impressive
reduction in cardiac CT radiation dose (41).
One of the potential applications of CT-MPI is in
the triage of patients with acute chest pain. Rest
CT-MPI evaluated concurrently during routine car-
diac CT shows promise in detection of perfusion
defects in the presence of acute coronary occlusion
(42). In a recent study, Feuchtner et al. (18) were
able to demonstrate that the evaluation of rest
myocardial CT-MPI in patients presenting with acute
chest pain improved the accuracy of cardiac CT
compared with SPECT, mainly by reducing the rate
of false-positive ﬁndings. A recent study by Pursnani
et al. (43) showed that early rest CT-MPI provided
incremental value beyond obstructive CAD to detect
acute coronary syndromes. Furthermore, coronary
CTA plus rest CT-MPI was noninferior to coronary
CTA plus SPECT (43).
One of the main shortcomings of CT-MPI is tech-
nical issues, such as beam hardening artifacts (BHA),
which originate by the polychromatic nature of x-rays
and the energy dependency of x-ray attenuation.
These artifacts lead to a considerable myocardial
signal density drop at regions adjacent to highly
attenuated structures such as the sternum, spine,
or descending aorta, thus resembling perfusion
defects.
Dual-energy CT imaging has recently emerged as
an appealing tool for CT-MPI given the ability of this
technique to reduce BHA by the generation of syn-
thesized monochromatic image reconstruction. There
are currently 3 approaches to evaluate CT-MPI using
dual-energy CT. The most widely used consists of a
CT scanner equipped with 2 independent x-ray tubes
and a set of detectors at an angular offset of 90 to 94
(depending on the generation), with 1 tube operating
at 80 or 100 kV and the other operating at 140 kV
(44,45). A second, more recent approach is based on
a CT scanner with a single x-ray tube capable of
ultrafast switching between 80 and 140 kV; therefore,
it might have the potential to overcome some limi-
tations of the former approach, such as increased
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1326scattered radiation and potential mismatch in the
projection views between high and low tube pro-
jections, when scanning moving objects such as the
heart (46,47). A third approach is the dual-layer
scanner consisting of 2 different scintillating mate-
rials fused together (sandwich). This application
permits higher-energy x-ray photons to pass through
the upper layer without having signiﬁcant interac-
tion, whereas the lower energy photons are mostly
diminished in the top layer. The signals from the top
and from the base constitute the 2 different energy
ranges that have exactly the same projection (48). A
number of studies have reported the incremental
value of dual-energy stress CT-MPI over anatomic
evaluation alone for the detection of reversible
perfusion defects assessed by SPECT in patients
with intermediate to high CAD likelihood (44,46,49).
Moreover, another study showed improved diag-
nostic performance compared with conventional
single-energy CT-MPI imaging, which was mainly
attributed to the attenuation of BHA (50).
TRANSLUMINAL ATTENUATION GRADIENT
AND CORRECTED CORONARY OPACIFICATION
Impairment of ﬂow due to signiﬁcant coronary ste-
nosis is a phenomenon very well-studied with ICA,
and its extent is assessed with Thrombolysis In
Myocardial Infarction (TIMI) ﬂow grades or corrected
TIMI frame counts (51). Cardiac CT allows for the
noninvasive assessment of coronary ﬂow given the
presence of isotemporal differences in contrast den-
sities (i.e., contrast attenuation) between proximal
and distal portions of the coronaries, especially
evident in the presence of stenosis (52,53). For a given
coronary cross section, the mean luminal contrast
opaciﬁcation in Hounsﬁeld units (HU) is utilized, and
several approaches have been described (54). Of note,
contrast attenuation–based methods may be inﬂu-
enced by the time-density curve of the intravascular
contrast agent and acquisition timing, as well as fac-
tors related to epicardial ﬂow other than the presence
of stenosis, which should be taken into account when
assessing these measures (54,55). Unlike other func-
tional tests that involve pharmacological stress,
contrast attenuation is currently assessed only in a
resting state.
TRANSLUMINAL ATTENUATION GRADIENT. Transluminal
attenuation gradient (TAG) is the most studied
attenuation-based method for the assessment of
functional relevance of coronary stenosis (Figure 2). It
involves the reconstruction of cross sections perpen-
dicular to the centerline of the vessel at 5-mm in-
tervals from the ostium to the distal level, where thevessel cross-sectional area falls below 2.0 mm2. TAG is
deﬁned as the linear regression coefﬁcient between
luminal contrast attenuation (HU) and length from the
ostium (cm) (53). The intended use of TAG is to better
classify lesions in which the anatomic information is
nonconclusive. Accordingly, lesion severity and pla-
que characteristics (i.e., calciﬁed, noncalciﬁed, or
mixed) are integral components of the evaluation,
especially because TAG has been shown to have a
greater beneﬁt in calciﬁed lesions (56).
Current data are insufﬁcient to recommend refer-
ence values for healthy arteries, and standard pro-
tocols for acquisition and interpretation may be
needed (57). Steigner et al. (53) studied 108 healthy
vessels from 36 patients using a 320-row multi-
detector computed tomography (MDCT) and showed
that TAG was lowest in the right coronary artery
(RCA) (6.5  4.1 HU/cm) and was similar for the left
anterior descending artery and left circumﬂex artery
(LCx) (13.7  8.0 HU/cm and 12.5  7.8 HU/cm,
respectively) (53). Cardiac phases correlated strongly
with TAG values in the RCA and LCx, whereas heart
rate showed a moderate correlation with those
observed in the LCx.
Cutoff values for determining the functional rele-
vance of coronary lesions have not been standardized
and are diverse, as reﬂected in Table 2 (55,56).
Nonetheless, TAG decreases consistently and signi-
ﬁcantly with maximum stenosis severity on a
per-vessel basis, especially in vessels with calciﬁed
lesions, as reported by Choi et al. (56) in a study
including 370 coronaries from 126 patients using a 64-
row MDCT scanner. Furthermore, the addition of TAG
to the interpretation of coronary CTA may improve
diagnostic accuracy, especially in the presence of
calciﬁed plaques (56,58).
Validation of TAG at rest for the determination of
functionally signiﬁcant stenosis using invasive
FFR <0.8 as a reference has yielded conﬂicting results
(59,60). Interestingly, in a study including 253 vessels
from 85 patients evaluated with a 256-row MDCT,
TAG did not provide incremental diagnostic accuracy
over coronary CTA alone (61). However, after correc-
tion of temporal nonuniformity and exclusion of
calciﬁed coronary segments, a slight improvement in
the net reclassiﬁcation index was observed. More-
over, in a study assessing 127 vessels in 75 patients
using a 320-row MDCT scanner, the investigators
observed that in vessels without signiﬁcant calciﬁ-
cation or artifacts, TAG plus coronary CTA provided a
comparable diagnostic accuracy when compared with
coronary CTA combined with CT-MPI, although the
sum of TAG þ coronary CTA þ CT-MPI offered the best
diagnostic accuracy (61).
FIGURE 2 Representative Examples of TAG Measurements
(A1) Calciﬁed lesion in mid-left anterior descending artery that was indeterminate by coronary computed tomography angiography, but diameter
stenosis was 28.7% by quantitative invasive coronary angiography. Red arrows correspond to stenotic sites. (A2) The intraluminal attenuation in
distal left anterior descending artery does not decrease, demonstrating no signiﬁcant obstruction. (A3)Cross-sectional viewswithgray border and
sloped legend in italics represent excluded intervals. (B) Severe stenosis is shown in both coronary computed tomography angiography and
invasive coronary angiography. It is conﬁrmed in cross-sectional views. Gray dots in A2 and B2 represent intervals that were excluded because of
signiﬁcant calciﬁcation or stenosis.Modiﬁedwith permission fromChoi et al. (56). DS¼diameter stenosis; HU¼Hounsﬁeld units;MLD¼minimum
lumen diameter; NG ¼ nitroglycerin; QCA ¼ quantitative coronary angiography; TAG ¼ transluminal attenuation gradient.
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TABLE 2 Studies Eva
Year
First Autho
(Ref. #)
2011 Choi et al. (56)
2012 Choi et al. (59)
2012 Yoon et al. (60
2013 Wong et al. (55
2014 Zheng et al. (5
2014 Wong et al. (79
2014 Stuijfzand et al
2015 Hell et al. (80)
2015 Wang et al. (81
CAG ¼ coronary angiograp
PPV ¼ positive predictive v
TABLE 1 Summarized Myocardial Perfusion Protocols
Static Stress MPI Dynamic Stress MPI
Scanner requirement 64-slice CT Second-generation
dual-source CT
Wide detector CT with complete
cardiac coverage
Acquisition mode ECG-triggered axial scan mode
ECG-gated spiral scan mode
ECG-triggered shuttle mode
(dual-source CT)
Stationary ECG-triggered mode
(wide detector CT)
Contrast protocol 50–70 ml @ 4–5 ml/s Short, high-rate bolus (z50 ml)
Image data Single high-resolution dataset Sequence of low-resolution
datasets
Effective dose 1–5 mSv* 5–10 mSv*
Output parameters Attenuation values
Relative attenuation values
Myocardial blood ﬂow
Myocardial blood volume
*Dose dependent on scanner technology and acquisition parameters.
CT ¼ computed tomography; ECG ¼ electrocardiogram; MPI ¼ myocardial perfusion imaging.
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1328CORRECTED CORONARY OPACIFICATION. CT scan-
ners that are not capable of acquiring the whole heart
in a single beat lack temporal uniformity for luminal
contrast assessment. This temporal misalignment
between subvolumes refers to differences in opaciﬁ-
cation induced by temporal changes between acqui-
sitions of the superior versus inferior subvolumes. A
proposed method to overcome this limitation is cor-
rected contrast opaciﬁcation (CCO), for which a quo-
tient of the mean intraluminal HU in a coronary
segment and the descending aorta in the same axial
plane is calculated. CCO is assessed by the analysis of
coronary CTA axial slices and calculates the quotient
in the intracoronary segment most proximal and most
distal to the stenosis. CCO is deﬁned as the difference
between these 2 quotients (59).luating TAG for the Identiﬁcation of Ischemic Lesions
r CT
Generation
No. of
Vessels (n)
Calciﬁed
Lesions (%) Reference
Improved
Diagnostic
Accuracy
64 370 (126) 27 CAG $50% Yes
64 97 (63) 32 FFR <0.80 Yes
) 64 82 (53) 29 FFR #0.80 NA
) 320 78 (54) 69 FFR #0.80 Yes
8) 64 309 (107) 37 CAG $50% Yes
) 320 97 (75) 39 FFR #0.80 Yes
. (61) 256 225 (85) 34 FFR #0.80 No
Dual-
source
72 (59) NA FFR #0.80 No
) Dual-
source
32 (32) NA FFR <0.80 No
hy; DS ¼ diameter stenosis; FFR ¼ fractional ﬂow reserve; HU ¼ Hounsﬁeld units; NA ¼ no
alue; Se ¼ sensitivity; Sp ¼ speciﬁcity; TAG ¼ transluminal attenuation gradient.Although CCO has been shown to predict abnormal
resting blood ﬂow (TIMI ﬂow grade <3, as determined
with ICA) (62), its utility is still controversial because
it does not improve diagnostic performance of CTA
alone and available data are scarce (59). However, a
combination of CCO with TAG has been proposed,
yielding an improved discrimination of signiﬁcant
lesions compared with TAG alone (61). Of note, in a
retrospective study including 106 patients treated
with prior stenting, CCO was associated with in-stent
restenosis severity in stents <3 mm in diameter (63).
FFR COMPUTED FROM CTA
Computational ﬂuid dynamics (CFD), as applied to
cardiac CT images, is a novel method that enables
prediction of blood ﬂow and pressure ﬁelds in coro-
nary arteries and calculation of lesion-speciﬁc FFR
(64–66). The FFR is computed from commonly ac-
quired MDCT scans (FFRCT) without any modiﬁcation
of cardiac CT protocols, additional image acquisition,
or administration of medications.
The FFRCT technology is based on 3 key principles.
The ﬁrst is that coronary supply meets myocardial
demand at rest (total resting coronary ﬂow is relative
to ventricular mass). The second is that resistance of
the microcirculation at rest is inversely but not line-
arly proportional to the size of the feeding vessel. The
third principle is that microcirculation reacts pre-
dictably to maximal hyperemic conditions in patients
with normal coronary ﬂow. On the basis of these
principles, a lumped parameter model representing
the resistance to ﬂow during simulated hyperemia is
applied to each coronary branch of the segmented
coronary CTA model. The FFRCT was modeled forCutoffs
and Components Se Sp PPV NPV
Signiﬁcant
NRI
#1.80 HU/cm þ DS $50% 84 94 96 75 Yes
#0.654 HU/mm þ DS $50% 90 63 63 90 No
#0.654 HU/mm 38 88 67 69 NA
#15.1 HU/cm 77 74 67 83 Yes
#11.33 HU/cm þ DS $50% 94 94 90 96 No
#15.1 HU/cm þ DS $50% 73 97 92 87 Yes
#7.51 HU/cm 69 44 83 27 No
#0.65 HU/mm 57 61 28 31 NA
#1.51 HU/mm 37 58 23 73 NA
t available; NPV ¼ negative predictive value; NRI ¼ net reclassiﬁcation improvement;
FIGURE 3 Fractional Flow Reserve CT
Standard coronary computed tomography angiography data are obtained. (A) The 5-year results following an Absorb implantation are shown. Arrowheads indicate the 2
metallic markers in the left anterior descending artery. Noncalciﬁed plaque results in 62% area stenosis. (B) A quantitative 3-dimensional anatomic model is generated.
(C) A physiological model of the coronary microcirculation is derived from patient-speciﬁc data with 3 main principles: 1) resting coronary ﬂow proportional to myocardial
mass; 2) microvascular resistance inversely proportional to vessel size; and 3) microvascular resistance reduced to simulate maximal hyperemia. (D) Physical laws of ﬂuid
dynamics are applied to compute coronary blood ﬂow. (E) Fractional ﬂow reserve computed tomography (FFRCT) is calculated throughout the coronary arteries. (F) From
the proximal to the distal edge of the scaffold, the FFRCT decreases from 0.88 to 0.80. Modiﬁed with permission from Garcia-Garcia et al. (78).
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1329conditions of adenosine-induced hyperemia; an
FFRCT #0.80 was considered to be diagnostic of
lesion-speciﬁc ischemia (67) (Figure 3).
The most advanced FFRCT is from HeartFlow
(Redwood City, California), and at present, there have
been 3 studies (67–69) using this technology (Table 3).
In all studies, FFRCT has been shown to be superior to
conventional cardiac CT and had good predictive ac-
curacies when compared with invasive FFR. Howev-
er, this technology requires processing on a powerful
remote computer for off-line analysis. The adjust-
ments of computational CT-based FFR algorithm by
reduced-order algorithm without the need for data
transfer have been developed to provide patient
management guidance within clinically viable time
frames (processing time <1 h). The feasibility of thisapproach has been tested by 2 retrospective studies
using a software research prototype (Siemens cFFR,
version 1.4, Siemens Healthcare, Malvern, Pennsyl-
vania; currently not commercially available) (70,71).
With this technique, the mean total time for proces-
sing and ﬂow computation was 51.9  9.0 min/study,
and there was a good direct correlation between CT-
based FFR and invasively derived FFR (Pearson’s
product-moment r ¼ 0.74; p < 0.0001). The validity of
an on-site algorithm compared with that of coronary
CTA has been reported with an accuracy for cFFR (area
under the curve 0.83) over coronary CTA alone (area
under the curve 0.64).
Besides the dependence on a remote evaluation
(with time-delay and additional cost issues), FFRCT
is associated with 2 other limitations. The ﬁrst is
TABLE 3 Trials Comparing FFR-CT (HeartFlow) and Invasive FFR
DISCOVER-FLOW (67) DeFACTO (68) NXT (69)
Publication year 2011 2012 2014
Patients proﬁle, n Stable CAD, 103 Stable CAD, 252 Stable CAD, 254
Coronary CTA $50%AUC 0.61 0.64 0.53
Coronary CTA $50%
Speciﬁcity 25% 42% 34%
Sensitivity 94% 84% 94%
PPV 58% 61% 40%
NPV 80% 72% 92%
FFRCT #0.80
AUC 0.87 0.73 0.81
Speciﬁcity 82% 54% 79%
Sensitivity 93% 90% 86%
PPV 85% 67% 65%
NPV 91% 84% 93%
Prevalence of FFR #0.80 56% 54% 42%
% patients excluded due
to nonevaluable scans
NA 12% 13%
CT generation $64 detector row $64 detector row $64 detector row
Primary CT reading Core laboratory Core laboratory Local investigator
Software version NA 1.2 1.4
AUC, speciﬁcity, sensitivity, PPV, and NPV are for per-patient analysis.
AUC ¼ area under the curve; CT ¼ computed tomography; CTA ¼ computed tomographic angiography;
DeFACTO ¼ Determination of Fractional Flow Reserve by Anatomic Computed Tomographic Angiography;
DISCOVER-FLOW ¼ Diagnosis of Ischemia-Causing Stenoses Obtained Via Noninvasive Fractional Flow Reserve;
FFR ¼ fractional ﬂow reserve; NPV ¼ negative predictive value; NXT ¼ Analysis of Coronary Blood Flow Using CT
Angiography: Next Steps; PPV ¼ positive predictive value.
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1330the dependence on very high image quality. In the
published studies performed in experienced cardiac
CT centers, even after excluding patients with high
body mass index, atrial ﬁbrillation, and previous
percutaneous coronary intervention or coronary artery
bypass graft, a signiﬁcant percentage of patients (up to
13%) were not evaluable due to insufﬁcient image
quality (Table 3). The other limitation is that infor-
mation about plaque burden is not considered for
the calculations, and recently, the relation between
atherosclerotic plaque features identiﬁed by coronary
CTA and the presence of ischemia has been underlined
(9,72).
EXTRAPOLATION FROM ATHEROSCLEROTIC
PLAQUE CHARACTERISTICS
Recently, the issue of whether functional informa-
tion can be extracted from the anatomic-based infor-
mation obtained with cardiac CT has been explored
further. In a study by Park et al. (72), the authors were
able to document an association between certain
atherosclerotic plaque characteristics (APCs), depicted
by coronary CTA (Figure 4, Table 4) and the presence of
ischemia by invasive FFR (72). In this study, 252 stable
patients without a previous revascularization proce-
dure were included and simultaneously evaluated bycoronary CTA and ICA, with FFR as gold standard for
functional signiﬁcance. Among the cardiac CT
obstructive ($50% stenosis) lesions, the authors found
that only one-half of them were functionally signiﬁ-
cant by FFR, and the independent predictors of
ischemia were lesion length, positive remodeling
(index $1.1), and the presence of low attenuation
plaque (<30 HU). The presence of 2 or more of these
APCs was associated with a 13-fold increased odds of
ischemia by invasive FFR, and spotty calciﬁcation,
another APC evaluated, was not an independent pre-
dictor of ischemia. In another study including 58 pa-
tients with intermediate stenosis on coronary CTA
undergoing ICA with FFR, aggregate plaque volume,
reﬂecting the extent of coronary atherosclerotic
burden, was incremental to several luminal nar-
rowing measurements (diameter stenosis, area ste-
nosis, minimum luminal diameter, minimum lumen
area) to predict functional signiﬁcance (FFR <0.80)
(9). In another small study evaluating 42 patients with
similar methodology, coronary CTA measurements of
area stenosis and lesion length were the strongest
determinants of an abnormal FFR (73).
The discordance between ischemia and stenosis has
been pointed out in several FFR studies. In a recent
prospective cohort of 1,000 patients evaluated simul-
taneously by ICA, IVUS, and FFR, up to 57% of the le-
sions with stenosis $50% had an FFR >0.80, and
conversely and more interesting, 16% of the non-
obstructive lesions were reversed mismatches,
because they were associated with FFR<0.80 (74). In
the coronary CTA study from Park et al. (72), the au-
thors also found a 17% rate of ischemia among non-
obstructive (<50% stenosis) lesions, which is
remarkable. The percentage of patients considered as
anatomy-functionmismatches has to be interpreted in
view of the threshold for signiﬁcant stenosis, and a
50% stenosis cutoff is not very ambitious and easily
leads to a signiﬁcant subgroup of false-positive pa-
tients (without ischemia, despite the presence of a
“signiﬁcant” stenosis). In this regard, their counter-
parts might be considered as “false negative” (with
ischemia, but without a signiﬁcant stenosis), and
this subgroup of patients might explain the worse than
expected prognosis of patients with nonobstructive
CAD but high disease burden, which has been exten-
sively documented with calcium scoring (75) and has
also been recently demonstrated with the use of cor-
onary atherosclerotic burden scores (76,77). Bitten-
court et al. (76) evaluated 3,242 patients without
known CAD referred for coronary CTA and followed up
for a median of 3.6 years and demonstrated that dis-
ease extent (as assessed by the number of seg-
ments with extensive disease [deﬁned as $5 segments
FIGURE 4 Extrapolation From Atherosclerotic Plaque Characteristics
In the left panels (A: volume-rendering technique; B and C: multiplanar reconstructions), coronary computed tomography angiography depicting a mixed
plaque in the mid-segment of the left anterior descending artery (LAD) with intermediate stenosis (50% to 70%) and several features that have been
associated with the presence of ischemia and/or future events: spotty calciﬁcation (A and B), positive remodeling (B and C), and low attenuation plaque (C). In
the right panels, the corresponding invasive coronary angiography image (D) and the result of the fractional ﬂow reserve (FFR), which was in the gray zone:
0.77 (E). The pink line in B represents the region depicted by the cross sectional image in C. The ﬁnal clinical judgment was to proceed to revascularization, and
the patient was submitted to percutaneous coronary intervention. Pa ¼ aortic pressure; Pd ¼ distal coronary pressure across the stenosis.
TABLE 4 Coronary CTA Plaque Characteristics Associated With Ischemia
Plaque Features Cutoff
Independent
Predictor of
Ischemia Ref. #
Area stenosis Per 5% Yes (72,73)
Lesion length Per mm Yes (72,73)
Positive remodeling >1.1 Yes (72)
Low attenuation plaque <30 HU Yes (72)
Spotty calciﬁcation <3 mm No (72)
Aggregate plaque volume, % per 5% Yes (9,72)
CTA ¼ computed tomographic angiography; HU ¼ Hounsﬁeld units.
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1331with CAD]) has independent and incremental prog-
nostic value for predicting cardiovascular death and
myocardial infarction. In another recent study,
Mushtaq et al. (77), using a more comprehensive CAD
burden index—the CT-Leaman score (CT-LeSc) with
information on lesion location, stenosis, and plaque
composition—evaluated the prognostic effect of
atherosclerotic burden among 1,304 patients under-
going coronary CTA for suspected CAD and followed
up for a mean of 52 months (77). The authors found
that event-free survival in nonobstructive (<50%
stenosis) CAD but high (>5) CT-LeSc was similar to
CENTRAL ILLUSTRATION Functional Evaluation by Cardiac CT
This illustration depicts the main features and current limitations of 4 different lines developed in the search for functional information with cardiac CT. CCO ¼ corrected
coronary opaciﬁcation; CT ¼ computed tomography; FFR ¼ fractional ﬂow reserve; MPI ¼ myocardial perfusion imaging; TAG ¼ transluminal attenuation gradients.
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1333obstructive CAD with high CT-LeSc but lower than
obstructive CAD with low CT-LeSc. These 2 studies
reinforce the concept that disease burden (either >5
segments with disease or a CT-LeSc >5) is an inde-
pendent long-term predictor of hard cardiac events
beyond stenosis severity and is in line with the results
of the studies linking APCs (72) and aggregate plaque
volume (9) with the presence of ischemia even
among (apparently) nonobstructive CAD lesions.
CONCLUSIONS
The discordance between ischemia and stenosis
that has been pointed out in several ICA and coronary
CTA studies and the central role that ischemia plays
in clinical decision making are both the main drivers
in the search for functional information in cardiac CT.
Several different lines have been reviewed in thepresent paper, as shown in the Central Illustration, and
although some of these areas require additional soft-
ware and hardware reﬁnements so that they can have
a more robust performance, the impressive develop-
ment of cardiac CT in recent years and its wide clinical
adoption leads us to believe that functional evalua-
tion of CAD by cardiac CT will certainly move from
research to a routine clinical tool in a near future.
Certain atherosclerotic plaque features, depicted
by coronary CTA, have recently emerged as possibly
related to the presence of ischemia and, more
importantly, might help to predict the future risk of
cardiovascular events.
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